Overview
Infera Health provides an AI-native continuous compliance platform for the medtech industry, helping medical device teams manage quality and regulatory tasks across design, build, and shipping. It monitors changes in a client’s workspace and keeps FDA documentation updated and auditable, while integrating Google Drive, Jira, Confluence, and GitHub to create a single system of record; AI agents analyze sources, extract requirements, generate system components, and identify risks. It differentiates itself by embedding continuous quality throughout development and offering FDA-ready templates for startups with scalable options for larger portfolios. Its goal is to speed up the delivery of life-saving medical devices by making quality engineering and regulatory compliance easy.
Work here?Claim your company
Simplify's take
What believers are saying
- FDA QMSR took effect February 2, 2026, increasing demand for continuous compliance tools.
- Vital Signals launched Signal Ring on July 20, 2026, validating Infera’s early customer base.
- Infera’s blog updated September 26, 2026, showing active category creation and product marketing.
What critics are saying
- Greenlight Guru, MasterControl, and Veeva already control entrenched medtech quality budgets.
- March 17, 2025 seed funding leaves Infera exposed if enterprise sales cycles drag.
- No named pilot customers beyond Vital Signals means a stalled pipeline can kill the company.
What makes Infera Health unique
- Infera turns medtech compliance into continuous workspace monitoring, not end-of-stage paperwork.
- Infera connects Google Drive, Jira, Confluence, and GitHub into one audit trail.
- Its agents automate requirements, architecture, risk, and documentation for ISO 13485 and IEC 62304.
Help us improve and share your feedback! Did you find this helpful?